Clinical trial
Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood…
NCT00133783 · Chang Gung Memorial Hospital, Other · Unknown status
Key facts
| NCT number | NCT00133783 |
|---|---|
| Title | Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure |
| Official title | Intermedin is an Estrogen- Modulated Factor for Reducing Blood Pressure |
| Lead sponsor | Chang Gung Memorial Hospital, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Menopause, Hypertension |
| Intervention type | Behavioral |
| Interventions | intermedin |
| Enrollment | 500 |
| Start date | May 1, 2005 |
| Completion | May 1, 2007 |
| First posted | Aug 24, 2005 |
| Last update posted | Oct 26, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: